2. QUALITATIVE AND QUANTITATIVE COMPOSITION
1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME SUBOXONE 2 mg/0.5 mg sublingual tablet SUBOXONE 8 mg/2 mg sublingual tablet 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Download 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
AUSTRALIAN PRODUCT INFORMATION PANADOL OSTEO …
www.medicines.org.au1 australian product information panadol osteo (paracetamol) tablets 1 name of the medicine paracetamol 2 qualitative and quantitative composition
Principles and Applications of LC-MS/MS for the ...
cdn.intechweb.org20 Principles and Applications of LC-MS/MS for the Quantitative Bioanalysis of Analytes in Various Biological Samples Ju-Seop Kang Department of Pharmacology & Clinical Phar macology Laboratory, College of Medicine;
DENOMINATION DU MEDICAMENT COMPOSITION …
a4mstatic.actito.netDENOMINATION DU MEDICAMENT Asaflow 80 mg et 160 mg, comprimés gastro-résistants COMPOSITION QUALITATIVE ET QUANTITATIVE Chaque comprimé d’Asaflow 80 mg – 160 mg contient respectivement 80 mg – 160 mg d’acide acétylsalicylique.
AUSTRALIAN PI HUMIRA (ADALIMUMAB) SOLUTION FOR ...
www.medicines.org.auHUMIRA PI Version 46 Clean Copy 29 October 2018 Page 1 of 88 AUSTRALIAN PI – HUMIRA® (ADALIMUMAB) – SOLUTION FOR SUBCUTANEOUS INJECTION 1 NAME OF THE MEDICINE Adalimumab (rch) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
NEW ZEALAND DATA SHEET 1. PRODUCT NAME
www.medsafe.govt.nzInternal document code cip200818iNZ 1 NEW ZEALAND DATA SHEET 1. PRODUCT NAME CIPROXIN® HC Ear Drops ciprofloxacin 0.2% and hydrocortisone 1%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Ciproxin HC Ear Drops contain …